Funded Startups in Burlingame
Across the 38 most recent Burlingame rounds, the largest disclosed amount is Eolian’s $463M (2025-10-09).
Across the 38 most recent Burlingame rounds, the largest disclosed amount is Eolian’s $463M (2025-10-09). That single figure dwarfs the next-largest disclosed rounds shown, including Lyra Health at $235M (2022-01-19) and Corvus Pharmaceuticals at $201M (2026-01-21), while many other disclosed rounds cluster far lower (e.g., multiple $20M–$34M deals such as quadric.io $30M on 2026-01-14 and StrongDM $34M on 2024-05-02). The list also concentrates in a long-but-front-loaded window: disclosed rounds span from 2020-05-27 (Tugboat Logic, $9M) to 2026-05-04 (Roadzen, $8M), with a dense run in 2024–2025 (e.g., Inflammatix $57M on 2024-09-12; Aven $110M on 2025-09-14; Cala Health $50M on 2026-04-20). Sector-wise, Artificial Intelligence (AI) appears repeatedly (Neurvona, xAI, Butlr, unitQ, Beehive AI, Signos, and Focal Systems), and “Series Unknown” is common: 17 of 38 entries use it (e.g., Roadzen $8M on 2026-05-04; Cala Health $50M on 2026-04-20; Eolian $463M on 2025-10-09).
Most recent rounds
38 shownRelated listings
Frequently asked
Which disclosed round is the outlier in this Burlingame set, and how far above the rest does it sit?
Eolian’s $463M (2025-10-09) is the only disclosed round above the ~$200M range. The next-largest disclosed entries shown are Corvus Pharmaceuticals at $201M (2026-01-21) and Proterra at $200M (2020-10-15), which sit well below Eolian’s figure.
How dense is the recent timeline—what span do these rounds cover, and who is at each temporal edge?
The 38 rows run from Tugboat Logic’s $9M on 2020-05-27 (oldest date shown) to Roadzen’s $8M on 2026-05-04 (most recent date shown). Most activity visually concentrates after 2021, including multiple disclosed rounds in 2024–2025 such as Inflammatix $57M (2024-09-12) and Aven $110M (2025-09-14).
Are any sectors or themes over-represented in Burlingame rounds here?
Artificial Intelligence (AI) is the clearest cluster, appearing across Neurvona (Pre-Seed, $600K on 2025-08-03), xAI ($10K on 2024-11-20), Butlr ($33M on 2024-08-26 and another $5M on 2023-03-22), unitQ (undisclosed on 2024-06-20), Signos ($20M on 2023-10-24), Beehive AI ($5M on 2023-06-01), and Focal Systems ($26M on 2021-11-01).
How often are deal stages missing, and does that skew toward certain companies?
“Series Unknown” appears in 17 of the 38 rows (including Roadzen $8M on 2026-05-04, Cala Health $50M on 2026-04-20, Eolian $463M on 2025-10-09, and unitQ with an undisclosed amount on 2024-06-20). There are also specific “undisclosed” amounts on unitQ (2024-06-20) and Onclusive (2022-08-02 debt financing).
Which entries are among the smallest disclosed amounts, and are they tied to any particular sector or stage?
The smallest disclosed amount is xAI at $10K on 2024-11-20, which sits far below even other small disclosed rounds like Psyched Services at $300K (2025-02-26) and Neurvona at $600K (2025-08-03). Both of those small-$ items are in adjacent AI-focused territory (xAI is AI; Neurvona is labeled AI).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.